Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Achillion Pharmaceuticals (NQ: ACHN )

6.760 USD UNCHANGED
Last Price Updated: 7:50 PM EST, Jan 27, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Achillion Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Achillion Pharmaceuticals Stock Forecast
Tags Syndication Cloud
From Syndication Cloud
Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
Achillion Shareholders Approve Agreement to be Acquired by Alexion
From GlobeNewswire News Releases
Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American
From GlobeNewswire News Releases
Rigrodsky & Long, P.A. Files Class Action Suit Against Achillion Pharmaceuticals, Inc.
From GlobeNewswire News Releases
Moore Kuehn, PLLC Encourages Investors of SRC Energy, Inc. (SRCI), Achillion Pharmaceuticals, Inc. (ACHN), and Arotech Corporation (ARTX) to Contact Firm
Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of... 
From PR Newswire
European Medicines Agency Grants PRIME Designation to Danicopan for Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients Who Are Not Adequately Responding to a C5 Inhibitor
– Phase 3 PNH initiation planned early 2020 – 
From GlobeNewswire News Releases
Achillion Announces Clearance of Investigational New Drug Application for ACH-5228
From GlobeNewswire News Releases
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies Is Fair to Shareholders - CISN, ACHN, VSI
From ACCESSWIRE
Achillion Reports Third Quarter 2019 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders - AYR, WLH, ACHN
From ACCESSWIRE
Achillion Announces Data Presentations at the 61st American Society of Hematology Annual Meeting
From GlobeNewswire News Releases
Merger Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders – LPT, CISN, IPHS, ACHN
From GlobeNewswire News Releases
Lifshitz & Miller LLP Announces Investigation of Achillion Pharmaceuticals, Inc., Anixter International Inc., Central European Media Enterprises Ltd., Digital Realty Trust, Inc., Fitbit, Inc., MutualF
From PR Newswire
Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies Is Fair to Shareholders – RARX, ACHN, IPHS, CISN
From GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, ACHN, RARX Shareholders About Its Ongoing Investigations
From GlobeNewswire News Releases
MERGER ALERT – ACHN, RARX, and IPHS: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies
From GlobeNewswire News Releases
Global Growth in Monoclonal Antibodies-How iCo Therapeutics Inc., Biogen, Provention Bio & Achillion Pharmaceuticals Win
Tags h:worldnews c:united/states c:canada
From EIN Presswire
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Acquisitions
From GlobeNewswire News Releases
ACHILLION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Achillion Pharmaceuticals, Inc. - ACHN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Achillion Pharmaceuticals, Inc. (NasdaqGS:... 
From Business Wire News Releases
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - CISN, IPHS, ACHN
From ACCESSWIRE
MERGER ALERT – ACHN, JAG, and ROAN: Levi & Korsinsky, LLP Notifies Investors of Investigations Concerning the Sale of these Companies
From GlobeNewswire News Releases
Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – IPHS, ACHN, RARX, TSG
From GlobeNewswire News Releases
SHAREHOLDER ALERT: WeissLaw LLP Investigates Achillion Pharmaceuticals, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Achillion Pharmaceuticals, Inc. ("ACHN" or the "Company") (NASDAQ: ACHN) in connection with... 
From PR Newswire
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues To Investigate Whether The Sale Of These Companies Is Fair To Shareholders - RARX, DOVA, ACHN
From ACCESSWIRE
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on Behalf of Achillion Shareholders and Encourages Achillion Investors to Contact
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on behalf of Achillion shareholders concerning the... 
From PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Achillion Pharmaceuticals, Inc. to Alexion Pharmaceuticals, Inc. is Fair to Shareholders
From GlobeNewswire News Releases
ACHILLION MERGER INVESTIGATION: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Achillion Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm
From GlobeNewswire News Releases
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Achillion Pharmaceuticals, Inc. has obtained a Fair Price in its sale to Alexion Pharmaceuticals, Inc.
Ademi & O'Reilly, LLP is investigating Achillion (NASDAQ:ACHN) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Achillion to Alexion. 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.